Drug Manufacturer: Depomed Inc (NASDAQ:DEPO), Teva Pharmaceutical (NYSE:TEVA), Endo Health Solutions (NASDAQ:ENDP), Dynavax Technologies (NASDAQ:DVAX)
Depomed Inc (NASDAQ:DEPO) stock was up 11.45 percent during trading on 3rd March on the back of strong preliminary results reported by the pharmaceutical firm on 25th February. Depomed Inc (NASDAQ:DEPO) stock opened at $13.62 in last session, and closed at $14.02, while the day range of DEPO stock is $13.44 – $14.19. The stock showed a positive weekly performance of 9.96%.
Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) announces the approval from the US Food and Drug Administration (FDA) to market the generic equivalent to Evista (Raloxifene) Tablets, 60 mg, in the United States. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock opened at $49.18, in last session and closed at $49.41, by gaining 1.27%. The 52 week range of TEVA is $36.26 – $50.70. Company’s market capitalization is $46.83billion.
Endo Health Solutions Inc (NASDAQ:ENDP) had its target price lifted by UBS AG from $75.00 to $90.00 in a research note released on Monday morning. Endo Health Solutions Inc (NASDAQ:ENDP) stock advanced 1.51% and finished the last session at $77.98. The EPS of the stock remained -5.58. Company’s market capitalization is $8.96billion.
Dynavax Technologies Corp. (NASDAQ:DVAX) has announced it will withdraw its European Marketing Authorization Application for its investigational hepatitis B vaccine. Dynavax Technologies Corporation (NASDAQ:DVAX) stock opened the session at $1.95, and closed the session at $1.99. The 52 week range of the DVAX stock remained $0.98 – $2.68 and the day range was $1.94 – $2.00.